Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Buspirone hydrochloride tablets (adults) - selected U.S. labeling
Product / population
Adult anxiety treatment with oral buspirone hydrochloride tablets; severe renal impairment requires special avoidance review.
Renal method
Indexed ClCr in the pharmacokinetic study; severe-impairment warning is qualitative.
Source revision
Label revision date not separately recorded; retrieval date is not the revision date.
Retrieved
2026-09-05
Local review status
Selected dosing/renal sections read; concise local summary, not full prescribing information.
Official
Buspirone hydrochloride tablets (adults) - selected U.S. labeling
U.S. product labeling / DailyMed · Adult anxiety treatment with oral buspirone hydrochloride tablets; severe renal impairment requires special avoidance review.
Renal method: Indexed ClCr in the pharmacokinetic study; severe-impairment warning is qualitative. Source date: Label revision date not separately recorded; retrieval date is not the revision date. Retrieved: 2026-09-05
Selected dosing/renal sections read; concise local summary, not full prescribing information.
Labeled basic dosing
Start 7.5 mg orally twice daily. If needed, increase total daily dosing by 5 mg at 2-3 day intervals; maximum 60 mg/day. Take consistently with respect to food.
RDM31-buspirone-label-dose · Source locator: Dosage and Administration
Renal information and dialysis
The label does not recommend use in severe renal impairment. Exposure was approximately fourfold greater in a study spanning ClCr 10-70 mL/min/1.73 m2. No validated numeric renal-dose algorithm is provided; dialysis removal is undetermined.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.